Stocksigma LogoStocksigma Logo

Eris Lifesciences Schedules Board Meeting for Q2 FY27 Financial Results

Eris Lifesciences has scheduled a Board of Directors meeting on 26th Oct'26 to consider and approve its standalone and consolidated unaudited financial

Eris Lifesciences Schedules Board Meeting for Q2 FY27 Financial Results

Eris Lifesciences Ltd 路 Intimation 路 26 Oct 2026, 5:30 am

Eris Lifesciences Schedules Board Meeting for Q2 FY27 Financial Results Eris Lifesciences has scheduled a Board of Directors meeting on 26th Oct'26 to consider and approve its standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the company's trading window closed on 1st Oct'26 and will remain shut until 48 hours following the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Eris Lifesciences Ltd

All Eris Lifesciences Ltd announcements